Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina V Chufarova

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutical Patent Analyst|December 21, 2013
Small-molecule arginase inhibitorsYan A Ivanenkov, Nina V Chufarova
Molecular Diversity|May 10, 2015
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property spaceYan A Ivanenkov, Mark S Veselov, Nina V Chufarova, et al.
Reviews in the Neurosciences|May 29, 2014
Computational approaches to the design of novel 5-HT6 R ligandsYan A Ivanenkov, Alexander G Majouga, Mark S Veselov, et al.
European Journal of Medicinal Chemistry|June 6, 2015
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonistsAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Journal of Medicinal Chemistry|August 23, 2014
Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025)Alexandre V Ivachtchenko, Oleg D Mitkin, Pavel M Yamanushkin, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2014
Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitorsYan A Ivanenkov, Sergei V Vasilevski, Elena K Beloglazkina, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutical Patent Analyst|December 21, 2013
Small-molecule arginase inhibitorsYan A Ivanenkov, Nina V Chufarova
Molecular Diversity|May 10, 2015
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property spaceYan A Ivanenkov, Mark S Veselov, Nina V Chufarova, et al.
Reviews in the Neurosciences|May 29, 2014
Computational approaches to the design of novel 5-HT6 R ligandsYan A Ivanenkov, Alexander G Majouga, Mark S Veselov, et al.
European Journal of Medicinal Chemistry|June 6, 2015
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonistsAlexandre V Ivachtchenko, Yan A Ivanenkov, Oleg D Mitkin, et al.
Journal of Medicinal Chemistry|August 23, 2014
Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025)Alexandre V Ivachtchenko, Oleg D Mitkin, Pavel M Yamanushkin, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2014
Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitorsYan A Ivanenkov, Sergei V Vasilevski, Elena K Beloglazkina, et al.
Pageof 1